Applied Genetic Technologies Corporation announced the appointments of Eduardo Jacobo, P.E., as Senior Vice President of GMP Manufacturing, and Dr. David Jacobs, MD, MBA, FACP, as Senior Vice President of Clinical Research and Medical Affairs. Eduardo Jacobo has over 30 years of experience in the healthcare industry, spending much of his time leading manufacturing, supply chain, quality, engineering, and process development functions. Eduardo comes to AGTC from Sangamo Therapeutics, where he led good manufacturing practice (GMP) gene therapy manufacturing efforts, including new facility commissioning.

Prior to this, he held positions of increasing responsibility across many manufacturing programs at several companies, including Amgen, Eli Lilly and Zimmer. Dr. David Jacobs is a highly regarded clinician and pharmaceutical executive who brings over 20 years of experience spanning all aspects of biopharmaceutical product development. Prior to joining AGTC, Dr. Jacobs led clinical programs from Phase 1 to Phase 4 across many therapeutic areas, including ophthalmology, the central nervous system, and gastrointestinal diseases, for several companies, including Biogen and Daiichi Sankyo.